Mirxes
Asia, Central Region, Singapore, Singapore'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Description
Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.
Investor Profile
Mirxes has made 1 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series A (100%)
Country Focus
- Vietnam (100%)
'%3e%3cpath id='a' fill='%23FF0' d='M0 0v6h4' transform='rotate(18)'/%3e%3cuse xlink:href='%23a' transform='scale(-1 1)'/%3e%3c/g%3e%3cg id='c' transform='rotate(72)'%3e%3cuse xlink:href='%23b'/%3e%3cuse xlink:href='%23b' transform='rotate(72)'/%3e%3c/g%3e%3cuse xlink:href='%23c' transform='scale(-1 1)'/%3e%3c/svg%3e)
Industry Focus
- Health Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
